Mouse Tumor Biology Database (MTB)
MTB Home   Help
Search for Help
 
in these sections
Search Forms
Tumor
Strain
Genetics
Pathology Images
Reference
Advanced
Search MTB Using Human Genes
Gene Expression Data Sets

Additional Resources
new PDX Like Me
PDX Finder
PDX Model Search
Faceted Tumor Search
Dynamic Tumor Frequency Grid
Other Cancer Websites
Immunohistochemistry
Lymphoma Pathology

Mouse Genome Informatics
The Jackson Laboratory
Citing These Resources
Warranty Disclaimer
& Copyright Notice

Send Questions and
Comments to User Support.

Last Database Update
2020-06-07
MTB 3.0
 
HelpHelp and Documentation Strain Search Results  
Search Summary
Sort By: Name
Display Limit: No Limit
20 matching items displayed.
Strain Name Strain Type Strain Notes
129/Sv-Krastm2Tyj/+ targeted mutation (knock-in) Heterozygous Krastm2Tyj mice on a 129/Sv background with possible contribution from 129S2/SvPas.
129S-Krastm2Tyj/+ targeted mutation (knock-in) Heterozygotes. The genetic background of these mice was stated to be greater than 90% 129/Sv. The other strains involved in this background were not specified.
129S-Krastm2Tyj/+ Trp53tm1Glo/+ targeted mutation (knock-in) Double heterozygotes. The genetic background of these mice was stated to be greater than 90% 129/Sv. The other strains involved in this background were not specified.
129S-Krastm2Tyj/+ Trp53tm1Tyj/+ targeted mutation (knock-in) &
targeted mutation (knockout)
Double heterozygotes. The genetic background of these mice was stated to be greater than 90% 129/Sv. The other strains involved in this background were not specified.
129S2/SvPas-Krastm2Tyj/+ targeted mutation (knock-in) Mice heterozygous for a targeted mutation of Kras. Spontaneous somatic recombination leads to the expression of an activated oncogenic KRAS protein. The genetic background was 129S2/SvPas.
B6;129S2-Krastm2Tyj/+ targeted mutation (knock-in) Mice heterozygous for a targeted mutation of Kras ("K-rasLA1"). Spontaneous somatic recombination leads to the expression of an activated oncogenic KRAS protein. The genetic background was a mix of C57BL/6 and 129S2/SvPas.
C57BL/6-Dicer1tm1.1Glo/+ Krastm2Tyj/+ targeted mutation (knock-in) Double heterozygous mice. These mice were "maintained in >90% C57BL/6 background." The genetic background also likely contained some 129S2/SvPas and some 129S6/SvEvTac.
C57BL/6-Krastm2Tyj/+ targeted mutation (knock-in) Heterozygous mice on a >95% C57BL/6 background that may also contain contributions from 129S2/SvPas. Kras knock-in only expressed after intrachromosomal recombination, unrecombined allele expresses no protein.
C57BL/6-Krastm2Tyj/+ targeted mutation (knock-in) Heterozygous mice. These mice were "maintained in >90% C57BL/6 background." The genetic background also likely contained some 129S2/SvPas and perhaps some 129S6/SvEvTac.
C57BL/6-Krastm2Tyj/+ Trp53tm1Tyj targeted mutation (knock-in) &
targeted mutation (knockout)
Compound mutant mice on a >95% C57BL/6 background that may also contain contributions from 129S2/SvPas. Kras knock-in only expressed after intrachromosomal recombination, unrecombined allele expresses no protein.
C57BL/6-Krastm2Tyj/+ Trp53tm3.1Glo targeted mutation (knock-in) Compound mutant mice on a >95% C57BL/6 background that may also contain contributions from 129S2/SvPas and 129S7/SvEvBrd. Kras knock-in only expressed after intrachromosomal recombination, unrecombined allele expresses no protein.
STOCK Krastm2Tyj/+ targeted mutation (knock-in) Heterozygous mice. This STOCK genetic background was a mixture of C57BL/6J, "129/SvJ", and BALB/cJ.
STOCK Krastm2Tyj/+ Trim62tm1Akil targeted mutation (knock-in) &
targeted mutation (knockout)
Heterozygous Krastm2Tyj, homozygous Trim62tm1Akil mice on mixed 129/Sv, C57BL/6J, and BALB/c background with possible contribution from 129S2/SvPas and/or 129/SvEv.
STOCK Krastm2Tyj/+ Trim62tm1Akil/+ targeted mutation (knock-in) &
targeted mutation (knockout)
Heterozygous Krastm2Tyj, Trim62tm1Akil mice on mixed 129/Sv, C57BL/6J, and BALB/c background with possible contribution from 129S2/SvPas and/or 129/SvEv.
STOCK Krastm2Tyj/+ Trim62tm1Akil/? targeted mutation (knock-in) &
targeted mutation (knockout)
Heterozygous Kras mutant mice carrying either one or two Trim62tm1Akil alleles on mixed 129/Sv, C57BL/6J, and BALB/c background with possible contribution from 129S2/SvPas and/or 129/SvEv.
STOCK Krastm2Tyj/+ Tg(Actb-Mdm4)15Glo targeted mutation (knock-in) &
transgenic
Compound mutant mice. This STOCK genetic background was a mixture of C57BL/6J, "129/SvJ", and BALB/cJ.
STOCK Krastm2Tyj/+ Tg(Actb-Mdm4)6Glo targeted mutation (knock-in) &
transgenic
Compound mutant mice. This STOCK genetic background was a mixture of C57BL/6J, "129/SvJ", and BALB/cJ.
[not specified]-Krastm2Tyj/+ targeted mutation (knock-in) Heterozygous mice ("K-rasLA1"). The genetic background of these mice was not specified. It contained some 129S2/SvPas and possibly some C57BL/6.
[not specified]-Krastm2Tyj/+ Trp53tm1Tyj targeted mutation (knock-in) &
targeted mutation (knockout)
Kras conditional mutant heterozygous and Trp53 KO homozygous mice. Spontaneous somatic recombination leads to the expression of an activated oncogenic KRAS protein. The genetic background was not specified.
[not specified]-Krastm2Tyj/+ Trp53tm1Tyj/+ targeted mutation (knock-in) &
targeted mutation (knockout)
Mice heterozygous for targeted mutations of Kras and Trp53. Spontaneous somatic recombination leads to the expression of an activated oncogenic KRAS protein. The genetic background was not specified.